Company

Cardiac Science


Cardiac Science issues AED recall

Industry News | Sunday, February 07 2010
 

Commentary: After AEDs saved his life, he crusades for their placement

Portal Exclusives | Thursday, July 23 2009
Written by Chris Knight
 

Cardiac Science books losses in 2008, replaces CEO

Financial News | Wednesday, March 18 2009
 

Cardiac Science unveils new exercise stress system

Conference News | Thursday, November 20 2008
 

Cardiac Science posts a 41% jump in Q3 income

Financial News | Thursday, November 06 2008
 

FDA warns of faulty Cardio Science AED devices

Regulatory News | Friday, November 20 2009
 

Report: Cost savings will drive ECG global market to nearly $160M by 2015

Financial News | Tuesday, July 14 2009
 

Cardiac Science to cut staff by 12%

Financial News | Wednesday, January 21 2009
 

Cardiac Science shifts around board of directors

Executive Announcements | Thursday, November 13 2008
 

Cardiac Science debuts new stress test, e-reporting system

New Products | Wednesday, October 29 2008
 


Web Exclusives

Commentary: Atrial fibrillation strikes an electrophysiologist

 Middle age introduces itself in many ways; one is atrial fibrillation (AF). My onset of AF seems to have coincided with a mountain bike accident in the woods of North Carolina that resulted in some cracked ribs.

AHRQ: Health IT could be disruptive while reducing rehospitalization rates, costs

 The use of health IT to reduce rehospitalizations will be welcome but also disruptive, said Stephen Jencks, an independent consultant in healthcare safety during a Feb. 24 webinar on the potential use of health IT to mitigate rehospitalizations, sponsored by the Agency for Healthcare Research and Quality (AHRQ).

New patient monitoring model draws scrutiny

 A new hospital breaking ground usually isn’t breaking news. But the vision of patient care at one new facility, tentatively named Palomar Medical Center West (PMC West), is currently illegal under California state law.

Commentary: Overcoming challenges with drug-eluting stents

 There are cases presented to all physicians when we have to balance benefits of a particular treatment with concerns around safety for certain patients. In interventional cardiology, we see this dilemma with drug-eluting stents (DES). While this technology provides effective therapy for many patients with ischemia-inducing coronary lesions, there are certain patient groups that encounter problems for different reasons.

Media-driven quality rankings leave out top-performing hospitals

 U.S. News & World Report and HealthGrades surveys that rank “Best Hospitals” according to their high-quality cardiovascular care do not create the most comprehensive list and may create confusion by excluding hospitals that provide the same quality of care, according to a study published in the January issue of the Journal of the American College of Surgeons.